GH Research (GHRS) EPS (Basic) (2020 - 2026)

GH Research (GHRS) posted quarterly EPS (Basic) of -$0.23 for Q4 2025, down 36.89% year-over-year from -$0.37 in Q4 2024, and down 2.46% quarter-over-quarter from -$0.23 in Q3 2025.

GH Research (GHRS) EPS (Basic) (2020 - 2026) Analysis & Trends

GH Research's EPS (Basic) history runs 6 years deep, the most recent figure standing at -$0.23 for Q4 2025.

  • In Q4 2025, EPS (Basic) fell 36.89% year-over-year to -$0.23; the TTM figure through Dec 2025 stood at -$0.79 (down 5.57% YoY), while the FY2025 annual figure was -$0.79, down 5.57% from the prior year.
  • EPS (Basic) for Q4 2025 stood at -$0.23, down from -$0.23 in the prior quarter.
  • The five-year high for EPS (Basic) was $0.01 in Q2 2022, with the low at -$0.32 in Q4 2022.
  • The 5-year median for EPS (Basic) is -$0.15 (2025), against an average of -$0.15.
  • The sharpest annual moves came in 2021 and 2022: EPS (Basic) tumbled 2922.87% in 2021, then jumped 108.57% in 2022.
  • GH Research's EPS (Basic) stood at -$0.09 in 2021, then slumped by 240.45% to -$0.32 in 2022, then soared by 32.04% to -$0.22 in 2023, then increased by 21.92% to -$0.17 in 2024, then slumped by 36.89% to -$0.23 in 2025.
  • Business Quant data shows GHRS's EPS (Basic) at -$0.23 in Q4 2025, -$0.23 in Q3 2025, and -$0.15 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 4.34
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 12.62
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 7.59
4 Revolution Medicines 43.64 Bn 43.64 Bn - -3.06
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.16
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 0.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.18
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.23
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -0.06
10 GH Research 2.02 Bn 1.68 Bn - -0.23

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.23
Dec 31, 2025 -0.23
Sep 30, 2025 -0.23
Jun 30, 2025 -0.15
Mar 31, 2025 -0.19
Dec 31, 2024 -0.17
Sep 30, 2024 -0.23
Jun 30, 2024 -0.20
Mar 31, 2024 -0.15
Dec 31, 2023 -0.22
Sep 30, 2023 -0.11
Jun 30, 2023 -0.15
Mar 31, 2023 -0.21
Dec 31, 2022 -0.32
Sep 30, 2022 -0.01
Jun 30, 2022 0.01
Mar 31, 2022 -0.13
Dec 31, 2021 -0.09
Sep 30, 2021 -0.06
Jun 30, 2021 -0.07